Instil Bio Inc (TIL) Directors and Executive Officers

Officers & Directors

Bronson Crouch
Chief Executive Officer and Chairman

Sandeep Laumas, M.D.
Chief Financial Officer and Chief Business Officer

Neil Gibson, Ph.D.
Director

R. Kent McGaughy, Jr.
Director

Jack Nielsen
Director

Gwendolyn Binder, Ph.D.
Director

George Matcham, Ph.D.
Director ,

Instil Bio Inc currently has 17 employees.

News about Instil Bio Inc Key Personnel

Instil Bio: Overcoming Financial Challenges and Paving the Way for Cancer Therapies

In exciting news in the field of biopharmaceuticals, Instil Bio, Inc. recently released a strategic update, outlining their path forward in developing revolutionary tumor infiltrating lymphocyte (TIL) therapies for patients battling cancer. The company, listed on NASDAQ as TIL, has been dedicated to finding innovative solutions for cancer treatment, but has faced significant financial challenges. A closer examination reveals that Instil Bio recorded a staggering net loss of $-197 million during the 12-month period ending in the third quarter of 2023, resulting in a discouraging negative return on investment (ROI) of -50.3%.
This financial setback undeniably poses a significant hurdle for the company...